[Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement].
The efficiency and safety of use of enoxaparin (clexane Rhone-Poulenc Rorer) in antithrombotic prophylaxis after total hip replacement is presented. The subcutaneous dose of 40 mg daily proved to be highly efficient and of minor side-effects.
Babiak
I
I
Kliniki Ortopedycznej AM w Warszawie.
Jabłoński
T
T
Serafin
J
J
D000328:Adult; D000368:Aged; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D017984:Enoxaparin
Enoxaparyna (clexane) w zapobieganiu powikłaniom zakrzepowo-zatorwym po całkowitej endoprotezoplastyce stawu biodrowego.